Program Schedule

320
VRE Colonization and Infection at the NIH Clinical Center (NIHCC)

Session: Poster Abstract Session: MRSA and VRE
Thursday, October 9, 2014
Room: The Pennsylvania Convention Center: IDExpo Hall BC
Posters
  • 2014 ID Week VRE poster.FinalDraft.pdf (2.3 MB)
  • Background: Vancomycin-resistant Enterococcus faecium (VRE) is a common cause of healthcare-associated infections. In 2009, VRE colonization/infection rates rose on the adult hematology-oncology wards at the NIHCC, prompting initiation of active surveillance cultures in 2009. Whereas colonization/infection rates subsequently declined, they did not return to baseline. We describe a cohort of 333 patients detected between 2007-2013 with VRE colonization or infection.

    Methods: Starting in July 2009, perirectal swabs were collected on admission and weekly from non-colonized patients and plated on selective media. In July 2010, swabs were tested by VanA/VanB PCR (Cepheid), replaced in Dec 2010 with VanA PCR. Patients with PCR+ results were cultured.

    Results: Surveillance swabs identified VRE colonization in 65%; clinical cultures identified 35%. Of 215 identified by active surveillance, 24% later grew VRE from clinical cultures. 

    Among the 215, 65% grew VRE in culture, and 35% had positive PCR, but negative cultures (PCR+/Cx-). Only 30% of PCR+/Cx- patients with subsequent swabs grew VRE from cultures. PCR+/Cx- swabs grew 41 organisms: vancomycin-susceptible E. faecium/faecalis (27%), vancomycin-resistant E. faecalis (5%), E. gallinarum/casseliflavus (44%), and others (24%). PCR had a positive predictive value of 43%, and 95% of identified organisms were not VRE.

    Of 140 with initial positive surveillance cultures, 33% grew VRE from clinical cultures. 32% had ≥3 subsequent negative swabs, but 21% later grew VRE a median of 46 days after the last negative surveillance culture.  

    Overall, 19% had VRE bacteremia. 44% of all patients died, including 49% initially identified in clinical culture, 72% of those who had VRE bacteremia, 44% identified in surveillance culture and 39% who were PCR+/Cx-.

    Conclusion: VRE colonization is tenacious; only 17% of our patients appeared to become decolonized. The low positive predictive value of PCR testing is likely influenced by vancomycin resistance genes in non-VRE bacteria. Mortality in patients with VRE colonization/infection is high, and colonization may be a surrogate marker for underlying disease severity. Understanding the dynamics of VRE colonization is essential for reducing its prevalence.

    Heather Y. Hughes, MD1, Robin T. Odom, M.S.2, Angela V. Michelin, M.P.H.2, Evan S. Snitkin, PhD3, David K. Henderson, MD, FIDSA4 and Tara N. Palmore, M.D.5, (1)National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, (2)Hospital Epidemiology Service, National Institutes of Health Clinical Center, NIH, Bethesda, MD, (3)National Human Genome Research Institute, NIH, Bethesda, MD, (4)National Institutes of Health Clinical Center, Bethesda, MD, (5)National Institutes of Health Clinical Center and National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD

    Disclosures:

    H. Y. Hughes, None

    R. T. Odom, None

    A. V. Michelin, None

    E. S. Snitkin, None

    D. K. Henderson, None

    T. N. Palmore, None

    See more of: MRSA and VRE
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek